(4 years, 10 months ago)
Commons ChamberI am grateful to the right hon. Member for his support and his words on the vaccination of pregnant women and the protection that the vaccine offers them.
On the right hon. Member’s question about the JCVI advice on 12 to 15-year-olds, the JCVI looked at the very narrow impact of the vaccine on 12 to 15-year-olds, because that is very much its remit. It also advised that the chief medical officers should take a wider look. That is what they are doing as we speak. Panels of experts from local public health as well as other experts are looking at the impact of the vaccine on mental health and the disruption to education specifically for 12 to 15-year-olds. They will come back with recommendations. The JCVI is observing those panels and is very much in the room, as far as that is concerned.
It is also worth reminding the House that the Medicines and Healthcare Products Regulatory Agency has looked at the Pfizer and Moderna vaccines and has approved both vaccines as safe and eligible to be administered to 12 to 15-year-olds. It is not worth our pre-empting the report of the chief medical officers of England, Wales, Scotland and Northern Ireland. Throughout the pandemic, we have operationalised the vaccine programme; we prepare early and we prepare well. To give the right hon. Member a direct answer to his question, the NHS is prepared to administer a vaccine within five working days of any recommendation. That does not pre-empt any recommendation. We did the same when none of the vaccines was approved. Some colleagues will recall Brigadier Phil Prosser explaining at the press conference that we had built the equivalent of the infrastructure of a national supermarket chain and were growing it by 20% every week. We have done the same thing when it comes to all outcomes of the deliberations at the JCVI and what it will ultimately recommend.
On education, the Secretary of State for Education addressed many of the issues on the mitigation and controls in schools, as well as testing and the very successful adult vaccination programme that we have delivered, which is now also delivering protection for 16 and 17-year-olds.
I really want to address the point about flu and I hope that we can have a sensible discussion on it. We are being very ambitious on flu. The interim advice from the JCVI is wherever possible to co-administer flu and covid vaccines. Traditionally, flu vaccination begins earlier—it begins now. One of the suppliers, Seqirus, has had a border issue with its Spanish fill-and-finish factory, which it has used for many, many years. This is the first time that it has had this issue. It is meeting the Spanish regulator to see what the issue is. It is being very careful and estimating a one or two-week delay. This will not delay the overall flu vaccination programme at all. Its German and Belgian supply chain has been flowing normally. It is one of the suppliers, so I urge the right hon. Gentleman not to, as a knee-jerk reaction, talk about flu vaccine shortages. We are being incredibly ambitious on flu vaccines—including procuring centrally as well as the traditional procurement through GPs and pharmacies—with a big, big programme.
Wherever possible, we will co-administer. The only caveat I would place on that is that the JCVI has given us only its interim advice on covid. We are not yet there with the cov-boost data, which it will look at. It will give us its final advice on covid. If it chooses a vaccine that requires, for example, a 15-minute observation period, we have a very different challenge in co-administration, but nevertheless, wherever possible, we will co-administer. We have made it possible for vaccinated volunteers to administer flu and covid vaccines.
Finally, on funding, I am glad that the right hon. Member agrees that the £5.4 billion announced today is a good thing. I urge him not to speculate on how we will pay for social care and to wait for the announcement; I am sure that we can then discuss it in this place and in the media.
I have great respect for the excellent job that my right hon. Friend is doing. He will know that Israel shows that even a good vaccination programme does not stop the Delta variant driving up hospitalisations. However, Israel also shows that a booster programme brings down those hospitalisations in as little as two weeks. Given that the big lesson from last year is that acting early can stop the need for lockdowns, as happened in Taiwan, Singapore, Korea and a number of other places, is this not a moment for Ministers to say, “Look, we understand that the scientists want to take their time, but we have a reasonable idea of what they are likely to recommend, so we are going to get on with this booster programme before it is too late”?
I am grateful for my right hon. Friend’s excellent question. I would say two things: first, in many ways, the decision taken by our chief medical officers in England, Wales, Scotland and Northern Ireland to increase the dosing interval, including for the vaccine that Israel uses—the Pfizer vaccine—from three to 12 weeks, with it now at an optimal eight weeks, was actually an inspired and clinically incredibly important decision, because it demonstrates, in real-world data, that the durability of the protection is increased over people who have had two jabs with a three-week dosing period. So we are in a slightly more advantageous position, if I can describe it as such.
My right hon. Friend makes an important point on boosters. The booster programme is probably the most important piece of the jigsaw yet to fall into place before we can transition this virus from pandemic to endemic status. I reassure him and the House that the NHS has all the plans in place to deliver the booster programme in what will, in some weeks, probably break our record, which we set in phase 1 of the vaccination programme. The JCVI has given us its interim advice on who needs to boost. It has added, obviously, the immunosuppressed to categories 1 to 4 and it has rightly recommended that we go big on flu. I am equally worried about that. Flu has been non-existent because of the severe social isolation of lockdowns and a big flu season could be detrimental as well. We are ready to go. As soon as cov-boost reports, which is imminent, we will be able to operationalise a massive booster programme.
(5 years ago)
Commons ChamberThe right hon. Gentleman asks who is included in the 3% pay rise recommended by the independent NHS Pay Review Body. They are the 1 million NHS staff, including nurses, paramedics, consultants and, of course, salaried GPs. The junior doctors he mentions have a separate, multi-year pay rise over three years, amounting to 8%.
The right hon. Gentleman asks about the capacity for testing. I looked at that before coming to the House, and the capacity currently for PCR tests is not 600,000 but 640,000 a day, according to the latest data that I looked at. He asks about schools. There will be two supervised tests for schools. He knows that in Monday’s statement we announced our acceptance of the JCVI guidelines on vaccinating vulnerable children, vaccinating children who live with vulnerable adults, and vaccinating those who are 17 but within three months of their 18th birthday. The JCVI will keep under review the vaccination of healthy children as more data becomes available from countries such as the United States of America and Israel.
The right hon. Gentleman asked a question around the covid vaccination pass and nightclubs, other crowded unstructured indoor settings such as music venues, large unstructured outdoor events such as business events and festivals, and very large structured events, such as business events, music and spectator sport events. They are the ones that we are most concerned about. We have seen other countries, whether it is Holland or Italy, opening nightclubs and having to reverse that decision rapidly. What we are attempting to do, and the reason we have the covid vaccination pass in place, is to work with industry while we give people over the age of 18 the chance to become double-vaccinated. It would be hugely unfair to bring in that policy immediately. Giving people until the end of September is the right thing to do, while at the same time allowing businesses to open safely, using the app now—because the app went live and the industry is very much engaging with it.
There are no easy decisions on anything to do with this virus. That is the one thing we have learned. The most effective tool we have against the virus is, of course, the vaccine programme, followed by the tool of self-isolation. If we want to get back to normal and get our lives back, we need to transition this virus from pandemic to endemic—from pandemic to manageable menace—as quickly and as safely as possible. If we release all restrictions now, including self-isolation, which I am sure a number of colleagues will ask about today, we risk the number of infections, which the shadow Secretary of State worries about as I do, rising rapidly. That could risk the transition of this virus.
We are working flat out with industry. I commend companies such as Lidl, which knows it is under pressure but will work through it with us. We will allow critical, frontline and key workers and health and social care workers to get back to work if they take a negative test, as I announced on Monday. By 16 August, everyone who is double-vaccinated will be able to do that.
May I start by wishing you and your family a ping-free summer, Mr Speaker? Thank you for upholding the values of this House over the past few months.
The Minister of State will have heard of YouGov, which said this week that a tenth of the people who had the NHS covid app have deleted it, and that a further fifth are considering doing so. Given that he made his living from listening to public opinion, does he not think it is time for the Government to listen to public opinion and immediately scrap the 10-day isolation requirement for double-jabbed people who are pinged, in favour of having to isolate until they take a negative PCR test? Otherwise we risk losing social consent for this very important weapon against the virus.
With your permission, Mr Speaker, I would briefly like to ask you about the issue we were not able to ask Ministers about in the House yesterday, which is the decision on NHS pay. I support the decision to accept the pay review body’s recommendations. It is the right thing to do, but it costs £1.5 billion. Can the Minister confirm it will not be paid for by cuts to other parts of the NHS budget? If it is going to be funded through a new national insurance rise for health and social care, as The Times says today, will he confirm that the funding for social care will be ring-fenced, so that we do not have a situation in which social care, once again, loses out because of pressures in the NHS?
The right hon. Gentleman said “you,” but I was not responsible for the decision yesterday.
(5 years ago)
Commons ChamberMay I start by echoing the Minister’s thanks to Lord Stevens, who is about to step down as chief executive of the NHS? One of my proudest achievements as Health Secretary was to secure a £20 billion annual rise in the NHS budget, and that would not have been possible without a close partnership with Lord Stevens. Indeed, he taught me a number of things about how to negotiate with the Treasury. He is someone who believes in the NHS to his fingertips, and he will be missed in all parts of the House, both on the Opposition Benches, but also on this side, where we have long forgiven him for his new Labour origins. We wish him well for the future.
This statement is about the NHS. The biggest pressure facing the NHS, apart from covid patients themselves, is the covid backlog, and I draw to the Minister’s attention the concerns that I and a number of people have as we face these enormous waiting lists. The previous Labour Government had considerable success in bringing down waiting lists, to their credit. They would also say that there were unintended consequences in terms of lapses in parts of the system with the safety and quality of care. Will the Minister, as we once again try to bring down waiting lists, agree that the Government will redouble their focus on safety and quality of care so that we do not have to relearn the lessons of Mid Staffs, Morecambe Bay and a number of other sad tragedies?
I thank my right hon. Friend for his question. I know that in his time as Health Secretary, he did a huge amount to raise the standards of safety and have a greater focus on patient safety in the NHS. That is still clearly making a difference today. He is absolutely right that we need to ensure that we focus on that as we work to bring down the backlogs from the pandemic. It is not only that; I am mindful of making sure that we continue to support our NHS workforce as they, on the one hand, look after patients with covid and, on the other, work to reduce the backlog. That pressure is continuing, but I am determined that as we bring down the backlog, staff will continue to be supported and will, in fact, continue to have time off, annual leave, the breaks they need and the wider support so that we look after our workforce as well as providing the care that patients need.
(5 years ago)
Commons ChamberThe hon. Gentleman raises a number of important questions. Pfizer supply remains consistent, and we have every confidence that the manufacturer will continue to deliver, as it has done, according to the delivery schedules. Being able to continue to vaccinate the over-18s with their first dose, and of course their second dose by the end of September is not a question of supply. Equally, as we did a few hours ago, jointly with Minister Humza Yousaf and the Ministers from Northern Ireland and Wales, we can take a decision that we will all follow JCVI advice on vaccinating vulnerable children and those who live with vulnerable adults, as I described in my statement.
On our capability in the UK to manage this pandemic, I hope, with the booster campaign in September, to transition from pandemic status to endemic status. With the wall of vaccinated adults—I think 87.9% have had a first dose in the United Kingdom, and 68% of all adults have had two doses—it is the right precautionary pragmatic decision to transition, and return our country to as normal a place as possible. We will get those businesses that were almost first in and now last out of the pandemic, back and up and running.
Thanks to the efforts of the Minister we have one of the best vaccine programmes in the world, so I hope he does not mind me expressing two concerns about our current strategy. First, if we are to introduce covid vaccine passports for nightclubs by the end of September, which I support, why are we waiting until then, and giving more weight to the concerns of people who want to go to nightclubs than to the additional extra cases that waiting two months is likely to cause, at a time when that growth of new cases is such a concern?
Secondly, on the NHS app, people who have been double jabbed know that if they are pinged they are less likely to have the disease. They are therefore starting to ignore the request to self-isolate, and in some cases to delete the app. Before we lose social consent, should we not replace the requirement to isolate for 10 days with a requirement for someone to isolate until they have had a negative PCR test, thus using that testing capacity that the Minister talked about to keep our national show on the road?
I am grateful to my right hon. Friend for his two excellent questions—rather than one—which I shall try to address in reverse. He will have heard the announcement in my statement about the NHS app and frontline social care or healthcare staff, as well as critical workers. Part of the reason we want to do that is that we want to maintain the ability of that workforce to do what it does best. As my right hon. Friend rightly outlined, they will do that with a negative PCR test and seven days of lateral flow testing. The clear clinical advice from the Chief Medical Officer and the expert team is that 16 August will be the most appropriate time to do that, for the rest of the economy as well. As we open up—we are now at step 4—and are getting more people double jabbed and protected further, especially younger parents, teachers and other professions, this is the appropriate measure to take on 16 August.
On the issue that my right hon. Friend raises on nightclubs, by the end of September 18-year-olds will have received their second dose. We will work with the industry to ensure that we get the covid pass right—now and in September—while we collate the evidence.
(5 years ago)
Commons ChamberTo reorganise the NHS as one of your first acts as Health Secretary is what Sir Humphrey would describe as brave. I support this Bill, because it contains changes that the NHS has asked for. I take the Secretary of State at his word that there is more to come on social care, and he has said that he will pursue the idea of independent safety and quality inspections of the new integrated care systems to make sure that they are outward facing and focused on the needs of patients.
When it comes to the biggest challenge facing the NHS today, which is workforce gaps, the Bill says little or nothing. Independent forecasts say today that we are currently short of 400 psychiatrists; 1,400 anaesthetists; 2,000 radiologists; 2,000 midwives; 2,000 to 2,500 emergency care consultants; and 2,500 GPs. We have more nurses but we are short of learning disability, mental health and community nurses.
It is unquestionable that we have a challenge with the GP workforce. It is about numbers, yes, but does my right hon. Friend agree that constituents have a big challenge with access to general practice? We currently do not have the right balance between telemedicine and in-person medicine.
There is a big issue, and my hon. Friend is aware from his time at the Department of Health that its root cause is capacity in the system. These capacity issues taken together are why the Health Foundation says that, in just over a decade, we risk a workforce gap in the NHS of about half a million people. That is why this is such a big issue. I urge the Secretary of State to think about that during the Bill’s passage.
Does my right hon. Friend agree that that is also the case for the rehabilitation services used by stroke victims? There is a vital link between occupational therapists and physios, but we do not have the proper workforce in place for at-home care after a stroke.
My hon. Friend is absolutely right. These issues are about not just doctors but all associated health professionals, allied health professionals and indeed the social care workforce. It is important to note that they predate the pandemic. That is why, when I was doing the job of my right hon. Friend the Secretary of State, I set up five new medical schools and increased the number of doctor, nurse and midwife training places by a quarter, but we need to go further.
When the number of clinicians we train is decided by haggling between the Department of Health and the Treasury in a spending round, there is always the risk that it will be eclipsed by more short-term considerations. The truth is that we have a short-term emergency with workforce burnout, so I urge my right hon. Friend to look at the simple and sensible solution proposed by the Health Foundation and all the royal colleges in The Times today to legislate for Health Education England to have a statutory responsibility to publish annual independent workforce projections across the health and care system for the next five, 10, 15 and 20 years. That would show how many training places are needed, which would start to tackle this problem and the obscenity of spending £6 billion every year on locum doctors and agency workers. That cannot be the best use of funds.
Frontline health and care workers are exhausted. They know that there is not an instant solution, because they know it takes three years to train a nurse and seven years to train a doctor, but we can at least give them the reassurance that there is a long-term plan in place. That is not in the Bill, but it needs to be. Given the dedication that we have seen from health and care staff over the last year, it is the very least that we owe them.
The hon. Lady makes a sensible point. There is obviously a process in place whereby that can happen, but if she is asking whether I agree with a liberal immigration policy to help our health service, then absolutely, yes I do. Addressing the cancer workforce and the wider NHS staffing picture is not an omission from the Bill—we cannot legislate staff shortages out of existence—but if we do not address that issue and face up to our long-term structural gaps, many of the reforms around tackling the backlog and building back better will not amount to a row of beans.
I congratulate my hon. Friend on the extraordinary work he did when he was a Minister on early diagnosis of cancer. Is he aware that the Health and Social Care Committee has just opened an inquiry—we had our opening session yesterday—into that issue, and into how we can get the right workforce in place to deal with those important matters?
I was aware of that, and I am pleased to hear it. The Select Committee will soon have Cally Palmer before it—she is the national cancer director and one of the best in the business—and I look forward to following what she says. In advance of the comprehensive spending review, the Bill should include a requirement on the Government to publish modelling of the future supply of the entire healthcare workforce.
On primary care, I welcome the formal creation of integrated care systems, but we need them to realise their potential, and to do so fast. If they are going to work, general practice needs to embrace the wider primary care family, which means finally to recognise the potential of community pharmacy, ophthalmology and dental services as vehicles of prevention as much as of treatment.
Finally, if we move upstream of the Bill, what we do must be about prevention. We hear talk this weekend of a waiting list touching 13 million people. Let us tackle that for sure, but let us also get behind the food and drink clauses in part 5, and think about the future and our children as much as about the present. Several years ago I was fortunate to write up the high fat, sugar and/or salt proposals as part of chapter 2 of the child obesity plan, and I am pleased that the 9 pm watershed is legislated for in the Bill. I pay tribute to Jamie Oliver and his Bite Back 2030 campaign, and the young people involved with that, as well as to Cancer Research UK for its support. I realise that not everyone on these Benches, or perhaps outside, supports that move, and I agree that it will have little impact if that is its grand sum. Ministers need to take the tackling obesity strategy that was published last year, implement it all, and then go again.
I welcome the clauses on the fluoridation of water supplies. Let us stop debating whether we do that and —to borrow a phrase—follow the science.
In conclusion, the Bill is worthy of support on Second Reading. There will be an awful lot of work to do in Committee and the other place, but I will certainly support it this evening.
(5 years ago)
Commons ChamberThe hon. Lady will know that the NHS long-term plan that has been set out by this Government is committed to a transformation in mental health services and mental health spending; some £2.3 billion extra is being invested by 2023-24. In addition, she will be aware of the mental healthcare White Paper and the mental health recovery action plan. I hope these are all initiatives she will support.
May I welcome the Secretary of State to his place? I am sure he will do an excellent job. As he thinks about a 24-hour A&E for Chorley, I hope he will also think about the urgent need for a cancer institute at the Royal Surrey County Hospital as only second on his list.
The Secretary of State will know that this morning the Health and Social Care Committee published a worrying report about the inhumane treatment given to 2,000 people with learning disabilities and autism in in-patient units, often because no community provision was available. When he brings forward his plans for social care, will he make sure that there is adequate funding for local authorities to give care to such people? Will he also make sure that care workers are always paid the minimum wage, including for the time taken to travel between appointments?
I welcome my right hon. Friend’s comments and the work that he and other Members do through the Select Committee to scrutinise the work of the Department. He just referred to some of that work, especially in his comments about learning disability and autism, which will remain a huge priority for the Government and certainly for my Department.
My right hon. Friend also rightly raised the issue of care workers and the minimum wage; it is worth pointing out that the Care Act 2014 requires local authorities, when they provide funding, not just to support the minimum wage but to take account of the costs that care workers might incur, such as travelling costs. I look forward to working with my right hon. Friend and the members of his Select Committee.
(5 years ago)
Commons ChamberThe right hon. Gentleman started by saying that he supports a balanced approach in a sustainable way, and that is exactly what I have set out today from this Dispatch Box. That is the Government’s approach, so I agree with him. We as the Government have set out the detail, but I am still not sure what his plan actually is. However, given that he set out those objectives, I hope he can support this plan. He talks about the risks that are involved, and I have been very up front about that. The Government have been up front: there is no risk-free way forward. Opening up is not without risk, but ongoing restrictions are not without cost, and I hope he appreciates that.
The right hon. Gentleman raised a number of questions, and one of his first was about hospitalisations. As I have said, case numbers are going up and we expect them to continue going up, but the most important difference today versus the last wave is vaccination—the wall of defence that our country has built—which has meant that hospitalisations, although they are rising as case numbers rise, are rising at a rate that is a lot slower than before. I have set out specifically regarding test 3 in a road map that we believe the pressure, with all the data we are seeing at this point, is not unsustainable for the NHS.
The right hon. Gentleman talked about vaccinations, and I am pleased he is highlighting that, especially for more young people to come forward. As I mentioned in my statement, we are ahead of the plans we set out when step 4 was temporarily pushed out by four weeks. He also asked about the vaccination of children. He knows that we have a group of expert science advisers—the Joint Committee on Vaccination and Immunisation—and this is something it is actively looking at. At some point, we will reach a final decision, but I hope he will agree with me that we should take the scientific advice on that and consider it very carefully before making such a move.
On air ventilation units, some of the £90-plus billion extra the Government have provided to the health and care system during the course of this pandemic has of course gone on air ventilation units, and we should continue to support that. A lot of extra funding has also gone to people to support them financially if they are asked to isolate, and it is important that that is both kept under review and continues to be taken seriously.
The right hon. Gentleman mentioned lateral flow tests and something about charging for them. That might be his policy, but it is not this Government’s policy. I do not know where he has got that one from, but we have no plans to charge for lateral flow tests.
Lastly, 19 July is a step forward on our road map. As we have clearly set out, the pandemic is not over, but it is a very significant step forward. The right hon. Gentleman talked about reviews. I have just said that we will have a review in September to make sure that we are properly set up for autumn and winter.
The virus today is a totally different creature from a year ago, with only one in 40 new cases being hospitalised, an average age for new cases of 25, and all over-40s being offered two jabs, accounting for 99% of the age group that have had covid fatalities to date, so the Government’s approach is entirely reasonable. However, does the Health Secretary agree that there remain, to paraphrase the late Donald Rumsfeld, a number of unknown unknowns and known unknowns, not least the impact of long covid, the potential for vaccine escape and the potential for new variants? Will he reassure the House that if the data deteriorates beyond what is currently envisaged, he will not hesitate to take decisive action, not just to save lives but to head off the need for a further lockdown which would be enormously damaging for our jobs and businesses?
I am very happy to give my right hon. Friend that assurance. He made some excellent points. I thank him for his support for the Government’s action, but he is right to point out that there is still uncertainty for us and countries across the world in dealing with this pandemic. I am very pleased to assure him that if that risk matrix changes, for example with variants of concern, we will not hesitate to take the appropriate action.
(5 years ago)
Commons ChamberWhat an honour it is to follow the hon. Member for Washington and Sunderland West (Mrs Hodgson); I remember from my time as Health Secretary what an incredibly powerful and passionate campaigner she was on all health issues, and she has done an enormous amount for families up and down the country through her campaigning in this place. I also thank the hon. Member for Kingston upon Hull West and Hessle (Emma Hardy) for her powerful comments and for securing this debate alongside my right hon. Friend the Member for Elmet and Rothwell (Alec Shelbrooke); both are formidable campaigners. I also particularly thank my right hon. Friend the Member for Maidenhead (Mrs May) for encouraging me to commission this review as Health Secretary. It was the right thing to do, and it reminded me of another great decision she made: to commission an independent investigation into the contaminated blood scandal, which was long overdue and which Prime Ministers prior to her had ducked. That was again an example of someone being prepared to do the right thing.
We would not be here if it were not for the hard work and dedication of my noble Friend Baroness Cumberlege. When I asked her to carry out this review in February 2018, neither of us had any idea quite what a huge job it would be. She set about the task with enormous energy and determination, and with the integrity to know that the job could not and would not be done properly until she had heard the stories of families up and down the country who had been damaged by what went wrong. I thank her, Sir Cyril Chantler and the entire team for their work and the clarity that they have brought to these difficult issues.
There has been the most terrible oversight of women’s medicine and medical devices. Until we implement the recommendations in the report, there will not be just a lack of justice, but also a risk of repeat.
I commend the Minister, who I know is personally deeply committed to patient safety. I know that, as a Minister, it is not always easy to get your way and to do all the things that you would like to do, because other people in the system overrule you. I know her heart is in the right place. I thank her for the fact that we have legislated for a Patient Safety Commissioner.
I understand the Government’s argument that it is not necessary to have an independent redress agency to implement a redress scheme, but we still do not have a redress scheme in this case. The risk of not having an agency is that every time we want to set up a scheme, there must be negotiations with the Treasury and the whole machinery of government combines to try to slow the process down. If we are to have justice in the future, we do not want that to happen.
On sodium valproate, I echo the comments of the hon. Member for Washington and Sunderland West. I remind the House that 400 babies are born every year to women on valproate. Half of those babies are harmed. As the hon. Lady rightly said, that is an underestimate because it does not include any stillbirths, miscarriages and terminations that may be associated with valproate.
The NHS took nearly a year to write to all the women of childbearing age on valproate, to warn them of the risks. I can understand why it took so long in the year that we have just had with the pandemic, but I am more concerned that the Medicines and Healthcare Products Regulatory Agency was approached as early as 2013 with the same issues. That identifies that we have a systemic problem that needs to be addressed.
I am also concerned that the letter that went out from the NHS simply had a warning about the dangers of valproate. Why did it not announce a ban on the routine prescription of valproate, saying that in future, it could only be prescribed through specialist channels, where we can absolutely make sure that the checks are in place to make sure that babies will not be harmed?
I am very concerned that the letter contains an ambition to halve the number of pregnant women on valproate by 2023. I cannot understand why we would just want to halve the number of pregnant women on valproate, when that would mean that 100 babies will continue to be born harmed every year. There can be no other proper ambition than to eliminate the number of babies born harmed by valproate and we need a plan to do that. It feels too much like that saying by Aristotle that the problem is not aiming too high and missing, but aiming too low and hitting. In this case, we must be aiming to prevent all harm to babies and to mothers.
My final point echoes many comments made by other hon. Members this afternoon. This is of course about justice, but it is also about learning. This time, it was valproate, Primodos and mesh. Next time, it will be different medicines and medical devices. I say to the Minister, only because I have been in exactly the same position as she is now on many, many occasions, that the only thing to do in this situation is to put your hand on your heart and ask yourself honestly and searchingly, “Am I absolutely sure that, having done what I am going to do, this can never happen again?” Until these nine recommendations are implemented, we will not be able to have the certainty that these mistakes will not be repeated. I think we need more pace and more ambition from the Government and I hope that is what we will hear when she makes her comments later.
(5 years ago)
Commons ChamberLet me turn to the right hon. Gentleman’s questions. First, he asked about infections. As I said yesterday from this Dispatch Box, we expect infections to continue to rise for the time being, for the reasons I set out yesterday. By 19 July, when we enter step 4, the advice we have received and the modelling suggests infections could be as high as 50,000 a day, double what they are now. Beyond that, as he says, we believe infections will continue to rise. As the modelling goes out further, it is less certain, but infections could go as high as 100,000 a day. I have been very up front about that.
What I have also been very clear about is that the reason we can make the decisions that we have made, as set out yesterday and today, with the decision just announced on self-isolation rules for those who are double vaccinated if they come into contact with someone who is infected, is because of the vaccine. The vaccine has been our wall of defence. Jab by jab, brick by brick, we have been building a defence against this virus.
Although no one can say at this point that the link between cases and hospitalisations has been definitively broken—there is not enough evidence for that—there is enough evidence to show us that the link between cases, hospitalisations and deaths has been severely weakened.
The right hon. Gentleman asked how many hospitalisations there have been or there may be. What I can tell him will help to demonstrate how this link has been severely weakened. In the last 24 hours, there have been approximately 27,000 reported new infections, and the total number of people in hospital in England with covid-19 is just under 2,000. The last time we had infections at that level, we were certainly above 20,000. That is a demonstration of how much the link has been weakened. In making sure that it stays that way, we of course want to see more and more people getting vaccinated. We have announced a booster programme that will start in September, to make sure that the immunity that comes from the vaccine remains.
The right hon. Gentleman also rightly talked about non-covid health problems, which a number of hon. Members have raised. I would like him to try to understand that one reason why so many people who wanted to go to the NHS with non-covid health problems such as cancer, heart disease and mental health problems but were prevented from doing so, is the restrictions that we had in place. The restrictions caused many of those problems—for example, the right hon. Gentleman should think about the mental health problems that have been caused by the restrictions. If we want to start dealing with non-covid health problems, we must start easing and moving away from the restrictions because of the protection that the vaccine has provided us. As the shadow Health Secretary, the right hon. Gentleman should be just as concerned about non-covid health problems, as I am, as he is about covid health problems.
The right hon. Gentleman also asked me about the immuno-suppressed. Again, he and other colleagues are absolutely right to raise this issue. The vaccines are there to protect everyone, including many people who are immuno-suppressed but who can take vaccines. For those people who cannot take vaccines, the fact that the rest of us do helps to protect them. We would them to take the same precautions that they would usually take in winter—for example, trying to protecting themselves against colds, flus and other viruses. I also encourage people to ensure that they are in contact with their GP to see what other measures or precautions they might be able to take.
Lastly, the right hon. Gentleman asked me about masks. He referred to a paper that I authored before I took this position, but he should understand that it is a strange question for him to ask. There is a role for masks in dealing with a pandemic, particularly when we have no wall of defence against it. When we have a vaccine, when that vaccine works and when we have the best vaccine roll-out programme in the world, we need to start moving away from restrictions, including on masks.
One of those other illnesses, apart from covid, that has been very badly affected by the pandemic is cancer. My right hon. Friend will know that, last year, 40,000 fewer people started cancer treatment, which will sadly lead to a number of preventable deaths. Will he be looking at the workforce required to deal with the cancer backlog? Will he also look at the capital requirements of many hospitals, including in my area? The Royal Surrey County Hospital is trying to build a cancer institute, but many hon. Members will have similar stories. May I make him a bold and generous offer to come in front of the Select Committee in September to talk about those plans? He can come for a couple of hours, but we do up to seven hours, should he so wish.
My right hon. Friend is absolutely right to raise the issue of cancer, and of course it is a huge priority for the Government. I mentioned earlier how, sadly, because of the rules that we have had in place for well over a year, there are many people who would have come forward to the NHS with cancer or suspected cancer, and they have not been seen. That has really built up a terrible problem, and it is an absolute priority for me to tackle with the workforce and with capital. Of course, I look forward to coming and sitting in front of my right hon. Friend’s Select Committee. I am not sure about the seven hours—I hope he will be a bit more lenient with me than that—but I do look forward to it.
(5 years ago)
Commons ChamberI thank the right hon. Gentleman for his comments. First, I think he started by asking for reassurance on whether the final decision on go or no go for 19 July, which we will make on 12 July, will be informed by the very best expert data. Of course it will be, just as every decision has been informed in that way. I am only about a week into the job, but I must say that I am incredibly impressed by our scientists, medical advisers and Public health England. I take this opportunity to pay tribute to all they have been doing.
Turning to the right hon. Gentleman’s second point about the link between cases and hospitalisation and death, that is absolutely central to the next step we are taking. Case numbers are high. As I said, they will go significantly higher and we need to be ready for that, but what is far more important is how many people are ending up in hospital and how many, sadly, are dying. That is where the vaccines have worked, alongside the treatments we now have that we did not have a year or so ago. That has meant that the link between cases and deaths has been severely weakened. The last time we had 25,000 new cases a day, we had around 500 deaths a day. The level now is a thirtieth of that. I know the right hon. Gentleman will welcome that and understand that there is no absolutely risk-free way to move forward, but we need to start returning things back towards normal and learning to live with covid.
The right hon. Gentleman asked about masks. Again, we have taken the best public health advice. He will know from what I have said that, although we will remove all legal requirements for anyone to wear a mask in any setting, we expect people to behave sensibly and think about others around them. The guidance will be there. If one is on public transport—let us say on a very crowded tube—it would be sensible to wear a mask, not least to show respect for others. However, if you are the only person in a carriage late at night on the east coast main line, then you can choose much more easily not to wear a mask because there is hardly anyone else around. We expect and trust people to make sensible decisions. That is the way we should move ahead.
The right hon. Gentleman asked about compensation and sick pay. He knows that many measures are in place and we will continue to keep them under review.
I support the approach the Secretary of State is taking for the simple reason that two doses of the vaccine work against the delta variant, but with 350,000 new cases daily across the world the battle against this pandemic is far from over. Does he agree that if we want to prevent another lockdown in the run-up to winter, apart from the booster jab programme the most important thing we can do is to improve the way test and trace works? In Korea, they managed to use it to stop any lockdowns. Here, it failed to stop three lockdowns. The head of test and trace told my Health and Social Care Committee that between 20% and 40% of people were not isolating when they were asked to. With his fresh eyes in the job, will he ask officials for new advice on what we can do to improve test and trace to stop further lockdowns?
First, may I thank my right hon. Friend for his support for the measures? He speaks with great experience and I want to thank him for that. Regarding test, trace and isolate, he is right. There are many successes over the past year that we can be proud of, but there are also many improvements that can be made. I have already asked for such advice and I look forward to talking to him about that in future.